Insulin resistance in type 1 diabetes
- PMID: 12112937
- DOI: 10.1002/dmrr.291
Insulin resistance in type 1 diabetes
Abstract
Insulin resistance plays a larger role in the type 1 diabetes disease process than is commonly recognized. The onset of type 1 diabetes is often heralded by an antecedent illness and/or the onset of puberty, both conditions associated with insulin resistance. In the face of a damaged beta-cell and thus reduced insulin secretion, this change is enough to manifest hyperglycemia. During the first year of clinical disease, considerable evidence suggests that the occurrence of clinical remission or 'honeymoon period' is due to a temporary resolution of the insulin-resistant state present at diagnosis. Intensive diabetes management is associated with both improved insulin sensitivity and beta-cell function. This indicates that the historical data on the changes in insulin secretion post-diagnosis may be inappropriate when designing current studies. The known physiological relationship between beta-cell function and insulin sensitivity complicates interpretation of insulin secretion data obtained as part of prevention or intervention trials. While it is recommended that at least a subset of subjects participating in these trials undergo formal measurements of insulin sensitivity to evaluate effects of therapy on this parameter independent of effects on the beta-cell, the sample size must be sufficient to determine an effect if present. Finally, one could speculate that it is possible that subsets of people with mild manifestations of the type 1 autoimmune disease process could benefit from treatments aimed at improving the insulin-resistant state.
Copyright 2002 John Wiley & Sons, Ltd.
Similar articles
-
Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.Postgrad Med J. 2016 Feb;92(1084):63-9. doi: 10.1136/postgradmedj-2015-133281. Epub 2015 Nov 30. Postgrad Med J. 2016. PMID: 26621825 Review.
-
Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and type 2 diabetes: Action LADA 9 [corrected].Diabet Med. 2014 Aug;31(8):941-5. doi: 10.1111/dme.12434. Epub 2014 Apr 9. Diabet Med. 2014. PMID: 24628669
-
Metabolic impact of puberty on the course of type 1 diabetes.Diabetes Metab. 2001 Sep;27(4 Pt 2):S19-25. Diabetes Metab. 2001. PMID: 11787432 Review.
-
[From insulin secretion to insulin therapy].Presse Med. 1998 Jul 4-11;27(24):1240-6. Presse Med. 1998. PMID: 9767787 French. No abstract available.
-
Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.Diabetes Metab. 1996 Dec;22(6):397-406. Diabetes Metab. 1996. PMID: 8985647 Review.
Cited by
-
Recent Insights into Glucose-Responsive Concanavalin A-Based Smart Hydrogels for Controlled Insulin Delivery.Gels. 2024 Apr 11;10(4):260. doi: 10.3390/gels10040260. Gels. 2024. PMID: 38667679 Free PMC article. Review.
-
Hypothesis: Induction of Autoimmunity in Type 1 Diabetes-A Lipid Focus.Diabetes. 2022 Oct 1;71(10):2067-2074. doi: 10.2337/db22-0240. Diabetes. 2022. PMID: 36126206 Free PMC article. Review.
-
The role of pancreas to improve hyperglycemia in STZ-induced diabetic rats by thiamine disulfide.Nutr Diabetes. 2022 Jun 20;12(1):32. doi: 10.1038/s41387-022-00211-5. Nutr Diabetes. 2022. PMID: 35725834 Free PMC article.
-
Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy.Front Pharmacol. 2021 Oct 25;12:768576. doi: 10.3389/fphar.2021.768576. eCollection 2021. Front Pharmacol. 2021. PMID: 34759828 Free PMC article. Review.
-
Islet isograft transplantation improves insulin sensitivity in a murine model of type 2 diabetes.Endocrine. 2021 Jun;72(3):660-671. doi: 10.1007/s12020-021-02655-8. Epub 2021 Mar 12. Endocrine. 2021. PMID: 33713015
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical